Solid Tumors — PankoMab-GEX™: Phase 1 Dose Escalation Study
Citation(s)
Phase I Dose Escalation Study Evaluating the Safety and Tolerability of PankoMab-GEX™ in Patients With Advanced, TA-MUC1 Positive Solid Malignancies Who Are Not Longer Eligible for Standard Therapy